New immunosuppressive drugs in dermatology (Mycophenolate mofetil, tacrolimus): Unapproved uses, dosages, or indications

被引：16
作者：
Assmann, T [1 ]
Ruzicka, T [1 ]
机构：
[1] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany
来源：
CLINICS IN DERMATOLOGY | 2002年 / 20卷 / 05期
关键词：
D O I：
10.1016/S0738-081X(02)00271-7
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：505 / 514
页数：10
相关论文
共 50 条
  • [31] Mycophenolate mofetil, a new immunosuppressive agent. Is pharmacokinetic monitoring necessary?
    Barre, J
    Simon, N
    Tillement, JP
    THERAPIE, 1997, 52 (02): : 139 - 142
  • [32] Similar Early Complication Rate in Simultaneous Pancreas and Kidney Recipients on Tacrolimus/Mycophenolate Mofetil Versus Tacrolimus/Sirolimus Immunosuppressive Regimens
    Girman, P.
    Lipar, K.
    Koznarova, R.
    Boucek, P.
    Kriz, J.
    Kocik, M.
    Havrdova, T.
    Adamec, M.
    Saudek, F.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (06) : 1999 - 2002
  • [33] A Comprehensive Review of Immunosuppressive Drugs in Pediatric Dermatoses: Part II - Methotrexate and Mycophenolate Mofetil
    Bose, Shiti
    Madke, Bhushan
    INDIAN JOURNAL OF PAEDIATRIC DERMATOLOGY, 2022, 23 (03) : 204 - 213
  • [34] Mycophenolate mofetil, Cellcept®, a new immunosuppressive drug with great potential in internal medicine
    Gregoor, PJHS
    van Gelder, T
    Weimar, W
    NETHERLANDS JOURNAL OF MEDICINE, 2000, 57 (06) : 233 - 246
  • [35] Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: The CASL experience with mycophenolate mofetil and tacrolimus
    Chatur, N
    Ramji, A
    Bain, V
    Ma, M
    Marotta, P
    Ghent, C
    Lilly, L
    Heathcote, J
    Deschenes, M
    Steinbrecher, U
    Yoshida, E
    GASTROENTEROLOGY, 2004, 126 (04) : A734 - A735
  • [36] Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen
    Sampaio, Edison L.
    Pinheiro-Machado, Paula G.
    Garcia, Riberto
    Felipe, Claudia R.
    Park, Sung I.
    Casarini, Dulce E.
    Moreira, Silvia
    Franco, Marcello F.
    Tedesco-Silva, Helio, Jr.
    Medina-Pestana, Jose O.
    CLINICAL TRANSPLANTATION, 2008, 22 (02) : 141 - 149
  • [37] A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation
    Pankewycz, Oleh
    Onan, Engin
    Rucker, Dane
    Wang, Dongliang
    Gruessner, Angelika
    Gruessner, Rainer
    Laftavi, Mark R.
    CLINICAL TRANSPLANTATION, 2020, 34 (07)
  • [38] Effects of immunosuppressive drugs on in vitro neogenesis of human islets:: Mycophenolate mofetil inhibits the proliferation of ductal cells
    Gao, R.
    Ustinov, J.
    Korsgren, O.
    Otonkoski, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (04) : 1021 - 1026
  • [39] Investigation of the optimal monitoring of mycophenolate mofetil and tacrolimus in renal transplant immunosuppressive therapy. Is there really no problem with trough monitoring?
    Uchida, K
    Tominaga, Y
    Haba, T
    Katayama, A
    Matsuoka, S
    Goto, N
    Ueki, T
    Takeda, A
    Morozumi, K
    Kimata, T
    Nagai, T
    Goto, Y
    Takagi, H
    Kobayashi, T
    Nakao, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 237 - 237
  • [40] The effects of immunosuppressive drugs - mycophenolate mofetil and cyclosporine A - on umbilical cord blood and peripheral blood T-cells
    Derniame, S.
    Madrigal, J. A.
    Saudemont, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S150 - S151
12345